Traders Sell Shares of Danaher (DHR) on Strength (DHR)
Investors sold shares of Danaher Co. (NYSE:DHR) on strength during trading hours on Tuesday. $49.89 million flowed into the stock on the tick-up and $93.13 million flowed out of the stock on the tick-down, for a money net flow of $43.24 million out of the stock. Of all stocks tracked, Danaher had the 0th highest net out-flow for the day. Danaher traded up $0.67 for the day and closed at $101.97
DHR has been the subject of several recent analyst reports. Zacks Investment Research cut Danaher from a “buy” rating to a “hold” rating in a research note on Friday, October 12th. Morgan Stanley increased their price target on Danaher from $122.00 to $126.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 10th. Finally, Robert W. Baird decreased their price target on Danaher from $116.00 to $114.00 and set an “outperform” rating for the company in a research note on Friday, October 19th. One investment analyst has rated the stock with a hold rating and fifteen have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $112.14.
The company has a market cap of $71.00 billion, a price-to-earnings ratio of 25.30, a PEG ratio of 1.95 and a beta of 1.04. The company has a quick ratio of 1.08, a current ratio of 1.53 and a debt-to-equity ratio of 0.38.
The company also recently announced a quarterly dividend, which was paid on Friday, October 26th. Investors of record on Friday, September 28th were paid a dividend of $0.16 per share. The ex-dividend date of this dividend was Thursday, September 27th. This represents a $0.64 annualized dividend and a yield of 0.63%. Danaher’s dividend payout ratio is currently 15.88%.
In related news, Director Donald J. Ehrlich sold 10,578 shares of the firm’s stock in a transaction dated Tuesday, October 23rd. The stock was sold at an average price of $95.77, for a total transaction of $1,013,055.06. Following the completion of the transaction, the director now owns 105,491 shares of the company’s stock, valued at $10,102,873.07. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Daniel L. Comas sold 36,000 shares of the firm’s stock in a transaction dated Thursday, November 8th. The shares were sold at an average price of $103.88, for a total value of $3,739,680.00. Following the transaction, the chief financial officer now directly owns 124,218 shares of the company’s stock, valued at approximately $12,903,765.84. The disclosure for this sale can be found here. Insiders have sold 150,007 shares of company stock valued at $15,202,163 in the last ninety days. Company insiders own 11.90% of the company’s stock.
Hedge funds and other institutional investors have recently made changes to their positions in the company. Gardiner Nancy B lifted its stake in Danaher by 5.8% in the 3rd quarter. Gardiner Nancy B now owns 9,110 shares of the conglomerate’s stock worth $991,000 after acquiring an additional 500 shares in the last quarter. Reilly Financial Advisors LLC lifted its stake in Danaher by 62.6% in the 3rd quarter. Reilly Financial Advisors LLC now owns 1,301 shares of the conglomerate’s stock worth $141,000 after acquiring an additional 501 shares in the last quarter. Securian Asset Management Inc lifted its stake in Danaher by 0.8% in the 2nd quarter. Securian Asset Management Inc now owns 62,119 shares of the conglomerate’s stock worth $6,130,000 after acquiring an additional 504 shares in the last quarter. Centaurus Financial Inc. lifted its stake in Danaher by 20.3% in the 2nd quarter. Centaurus Financial Inc. now owns 3,026 shares of the conglomerate’s stock worth $299,000 after acquiring an additional 510 shares in the last quarter. Finally, Whitnell & Co. lifted its stake in Danaher by 2.1% in the 3rd quarter. Whitnell & Co. now owns 25,270 shares of the conglomerate’s stock worth $2,746,000 after acquiring an additional 514 shares in the last quarter. 77.31% of the stock is owned by institutional investors and hedge funds.
TRADEMARK VIOLATION WARNING: “Traders Sell Shares of Danaher (DHR) on Strength (DHR)” was first reported by Daily Political and is the property of of Daily Political. If you are viewing this report on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The correct version of this report can be accessed at https://www.dailypolitical.com/2018/11/21/traders-sell-shares-of-danaher-dhr-on-strength-dhr.html.
About Danaher (NYSE:DHR)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Read More: What is the Coverage Ratio?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.